Craig A. Johnson, Director at Mirati Therapeutics, Inc. (MRTX), sold 29,956 shares at $214.75 ($6.3M) on 2021-01-21, disclosed to the SEC on 2021-01-25.
Open-market sale of $6.3M MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $210.01 | 3,505 | $736K | 11.6% |
| 2 | $210.01 | 3,505 | $736K | 11.6% |
| 3 | $210.81 | 3,183 | $671K | 10.6% |
| 4 | $210.81 | 3,183 | $671K | 10.6% |
| 5 | $211.94 | 4,562 | $967K | 15.3% |
| 6 | $211.94 | 4,562 |
| $967K |
| 15.3% |
| 7 | $212.97 | 3,372 | $718K | 11.3% |
| 8 | $212.97 | 3,372 | $718K | 11.3% |
| 9 | $213.62 | 44 | $9K | 0.1% |
| 10 | $214.75 | 334 | $72K | 1.1% |
| 11 | $214.75 | 334 | $72K | 1.1% |
| Total | $211.55 avg | 29,956 | $6.3M | 100% |
| Filing → |
| HRTX | SELL | 2021-06-22 | $4K | — | Filing → |
| HRTX | SELL | 2021-04-07 | $4K | — | Filing → |
| ODT | BUY | 2020-12-31 | $51K | — | Filing → |